Summary
- Current Price
- As of today, SMMT price is $13.35, down -4.64% on
- Current Price All-Time High
- SMMT price is currently -63.83% below its historical high of $36.91 set on
- Market Cap
- SMMT current market cap is $11B, down -45.79% year-over-year
- Revenue
- SMMT current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for SMMT is on
Profile
| Metric | Value |
|---|---|
| Full Name | Summit Therapeutics Inc. |
| Ticker | NASDAQ: SMMT |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | smmttx.com |
| Employees | 159 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $13.35 | |
| Price, 1D Change | -4.64% | |
| Market Cap | $11B | |
| - | ||
| PE Ratio | - | |
| Beta | 1.57 | |
| Revenue | $0.00 | |
| Revenue, 1Y Change | 0.00% | |
| EPS | -$1.44 | |
| EPS, 1Y Change | -368.80% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | -$1.44 | |
| EPS Estimate | - | N/A |
| EPS Est. Change | - | N/A |
| Revenue | $0.00 | |
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | $13.35 | |
| Price Target | $33.37 | - |
| Price Tgt. Change | +149.98% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | -$0.99 | - | |
| - | -$0.31 | - | |
| - | -$1.44 | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | $0.00 | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | -49.53% | |
| Price, 3Y | +574.24% | |
| Market Cap, 1Y | -45.79% | |
| Market Cap, 3Y | +670.94% | |
| Revenue, 1Y | 0.00% | |
| Revenue, 3Y | -100.00% | |
| EPS, 1Y | -368.80% | |
| EPS, 3Y | -254.33% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $13.35 | |
| SMA 200 | $16.76 | |
| SMA 50 | $14.24 | |
| EMA 200 | $16.86 | |
| EMA 50 | $14.65 | |
| MACD | -$0.16 | |
| Beta | 1.57 | |
| ATR | $0.85 | |
| 14-Day RSI | 44.13 | |
| 10-Day Volatility | 69.34% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $0.00 | |
| EPS | -$1.44 | |
| Gross Profit | -$146.00K | |
| Gross Margin | - | |
| Operating Income | -$1.09B | |
| Operating Margin | - | |
| Net Income | -$1.08B | |
| Net Margin | - | |
| EBITDA | -$1.09B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | 0.03 | |
| 9.87 | ||
| 9.87 | ||
| - | ||
| - | ||
| 61.16 |
Valuations
| Metric | Value | Date |
|---|---|---|
| PE Ratio | - | |
| - | ||
| 16.91 | ||
| -11.41 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | $658.86M | |
| $713.76M | ||
| $751.18M | ||
| $720.30M | ||
| $92.32M | ||
| $72.99M | ||
| Total Debt | $20.89M | |
| $3.39M | ||
| $20.29M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $1.08B | ||
| $1.09B | ||
| $146.00K | ||
| $0.00 | ||
| $146.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$322.93M | ||
| -$174.31M | ||
| $617.53M | ||
| Capex | $657.00K | |
| -$323.59M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Stifel | → | |
| Guggenheim | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Bernstein | ||
| HC Wainwright & Co. | → | |
| Piper Sandler | → | |
| Stifel | → | |
| Jefferies | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with SMMT
FAQ
- What is the ticker symbol for Summit Therapeutics Inc.?
- The ticker symbol for Summit Therapeutics Inc. is NASDAQ:SMMT
- Does Summit Therapeutics Inc. pay dividends?
- No, Summit Therapeutics Inc. does not pay dividends
- What sector is Summit Therapeutics Inc. in?
- Summit Therapeutics Inc. is in the Healthcare sector
- What industry is Summit Therapeutics Inc. in?
- Summit Therapeutics Inc. is in the Biotechnology industry
- What country is Summit Therapeutics Inc. based in?
- Summit Therapeutics Inc. is headquartered in United States
- When did Summit Therapeutics Inc. go public?
- Summit Therapeutics Inc. initial public offering (IPO) was on March 5, 2015
- Is Summit Therapeutics Inc. in the S&P 500?
- No, Summit Therapeutics Inc. is not included in the S&P 500 index
- Is Summit Therapeutics Inc. in the NASDAQ 100?
- No, Summit Therapeutics Inc. is not included in the NASDAQ 100 index
- Is Summit Therapeutics Inc. in the Dow Jones?
- No, Summit Therapeutics Inc. is not included in the Dow Jones index
- When was Summit Therapeutics Inc. last earnings report?
- Summit Therapeutics Inc.'s most recent earnings report was on July 23, 2026
- When does Summit Therapeutics Inc. report earnings?
- The next expected earnings date for Summit Therapeutics Inc. is October 19, 2026
Data Sources & References
- SMMT Official Website www.smmttx.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1599298/000159929826000015/0001599298-26-000015-index.htm
- SMMT Profile on Yahoo Finance finance.yahoo.com/quote/SMMT
- SMMT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/smmt